|
|
Volumn 49, Issue , 1995, Pages 641-673
|
|
Prospects for new interventions in the treatment and prevention of mycobacterial disease
|
|
Author keywords
drugs; immunity; mycobacteria; tuberculosis; vaccines
|
|
Indexed keywords
ANTIMYCOBACTERIAL AGENT;
BACTERIAL ANTIGEN;
BACTERIAL VACCINE;
BCG VACCINE;
CIPROFLOXACIN;
CLINAFLOXACIN;
ETHAMBUTOL;
HEAT SHOCK PROTEIN;
ISONIAZID;
LEVOFLOXACIN;
LIVE VACCINE;
MYCOLIC ACID;
NEW DRUG;
OFLOXACIN;
PEPTIDOGLYCAN;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
RIFABUTIN;
RIFALAZIL;
RIFAMPICIN DERIVATIVE;
SPARFLOXACIN;
ANTIBIOTIC RESISTANCE;
BACTERIAL CELL WALL;
BACTERIAL MUTATION;
BACTERICIDAL ACTIVITY;
CLINICAL TRIAL;
DRUG DELIVERY SYSTEM;
DRUG SCREENING;
GENETIC SUSCEPTIBILITY;
HUMAN;
IMMUNE RESPONSE;
IMMUNOTHERAPY;
MINIMUM INHIBITORY CONCENTRATION;
MYCOBACTERIOSIS;
MYCOBACTERIUM AVIUM;
MYCOBACTERIUM INTRACELLULARE AVIUM;
MYCOBACTERIUM TUBERCULOSIS;
NONHUMAN;
PRIORITY JOURNAL;
REVIEW;
T LYMPHOCYTE;
TUBERCULOSIS;
BACTERIA (MICROORGANISMS);
CORYNEBACTERINEAE;
MYCOBACTERIUM;
MYCOBACTERIUM AVIUM;
MYCOBACTERIUM AVIUM-INTRACELLULARE;
MYCOBACTERIUM INTRACELLULARE;
MYCOBACTERIUM TUBERCULOSIS;
|
|
EID: 0028879494
PISSN: 00664227
EISSN: None
Source Type: Book Series
DOI: 10.1146/annurev.mi.49.100195.003233 Document Type: Review |
|
Times cited : (97)
|
|
References (0)
|
